Table 2.
Rate of seroconversion in patients and controls 1 and 6 mo after 1st dose and 1 mo after 2nd dose of HA vaccine
| Time |
Patients
(n = 11) |
Controls
(n = 13) |
P |
| n (%) | n (%) | ||
| 1 mo after the 1st dose of HA vaccine | |||
| Positive | 7 (63.6) | 13 (100) | 0.07 |
| Equivocal | 2 (18.2) | 0 | |
| Negative | 2 (18.2) | 0 | |
| 6 mo after the 1st dose of HA vaccine | |||
| Positive | 7 (63.6) | 13 (100) | 0.09 |
| Equivocal | 3 (27.3) | 0 | |
| Negative | 1 (9.1) | 0 | |
| 1 mo after the 2nd (booster) dose of HA vaccine | |||
| Positive | 11 (100) | 13 (100) | 0.63 |
| Equivocal | 0 | 0 | |
| Negative | 0 | 0 |
HA: Hepatitis A.